News for NANOVIRICIDES, INC. (NNVC)

News for NANOVIRICIDES, INC.
Date Headline
Aug 07, 2018 07:00 AM NanoViricides Reports Its Topical Dermal Shingles Candidates Effective in Reducing Pain in Animal Study
Jul 23, 2018 07:00 AM NanoViricides, Inc. Welcomes Dr. Irach Taraporewala as the New CEO
Jul 12, 2018 07:00 AM NanoViricides Provides Update on Recent Events
Jun 26, 2018 07:00 AM Progress of NanoViricides' Shingles Drug Program Presented at the 31st International Conference on Antiviral Research
Jun 19, 2018 07:20 AM Wired News – AbbVie Presents New Undetectable Minimal Residual Disease Data from Phase-3 MURANO Trial of Venetoclax with Rituximab at 23rd European Hematology Association Annual Congress
May 22, 2018 07:00 AM NanoViricides Files Quarterly Report for Period Ending March 31, 2018; Company Has Over A Year's Worth of Cash in Hand, and It Is Scaling Up Production of Certain Herpecide Program Drug Candidates
May 22, 2018 05:02 AM NanoViricides: Fiscal 3Q Earnings Snapshot
Apr 09, 2018 07:00 AM NanoViricides Reports Good Safety Profile of Topical Dermal Drug Candidates; Dr. Diwan, President, Will Present at the MicroCap Conference in New York City Today
Mar 19, 2018 11:12 AM NanoViricides Drug Candidates to be Tested in Animal Models of Dermal, Ocular and Genital Herpes Virus Infection at the University of Wisconsin
Mar 05, 2018 06:19 PM Is NanoViricides Inc’s (NYSEMKT:NNVC) CEO Paid Enough Relative To Peers?